Posted by Michael Wonder on 17 Jul 2026
Orasis Pharmaceuticals announces Australia submission of a new drug application for Beska for the treatment of presbyopia
15 July 2026 - Orasis Pharmaceuticals and Aspen Australia announced that Aspen has submitted a new drug application in Australia to the TGA for the review and approval of Beska (pilocarpine hydrochloride ophthalmic solution) 0.4% for the treatment of presbyopia in adults (known as Qlosi in the US market).
Aspen will be responsible for the distribution and marketing of Beska in Australia.
